Related Experiment Videos
Dendritic oligoguanidines as intracellular translocators
Hyun-Ho Chung1, Guido Harms, Churl Min Seong
1LG Biomedical Institute, 3252 Holliday Court, Suite 101, La Jolla, CA 92037, USA.
Biopolymers
|March 5, 2004
Summary
New nonpeptidic dendritic oligoguanidines effectively translocate through cell membranes, acting as molecular translocators. These novel dendrimers show potential for intracellular drug and protein delivery.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cell Biology
Background:
- Developing efficient molecular translocators is crucial for targeted intracellular delivery.
- Nonpeptide-based carriers offer potential advantages over traditional peptide-based systems.
- Dendrimers, with their branched architecture, present unique opportunities for drug delivery applications.
Purpose of the Study:
- To design and synthesize novel polyguanidylated dendritic structures as nonpeptide molecular translocators.
- To evaluate the cellular uptake and translocation efficiency of these dendrimers.
- To assess their potential as carriers for intracellular delivery of various cargos.
Main Methods:
- Synthesis and characterization of polyguanidylated dendritic oligoguanidines.
- Conjugation of dendrimers with fluorescent cargos (fluorescein, green fluorescent protein mutant).
- Cellular uptake studies using HeLa S3 and human cervical carcinoma cells with quantification and time-course analyses.
- Deconvolution microscopy for intracellular localization analysis.
Main Results:
- Successfully synthesized and characterized dendritic oligoguanidines.
- Demonstrated cellular uptake and translocation across the cell membrane.
- Achieved translocation efficiency comparable to the Tat(49-57) peptide.
- Confirmed intracellular localization of the dendrimer conjugates via microscopy.
Conclusions:
- Nonlinear, branched dendritic oligoguanidines can effectively translocate through the cell membrane.
- These nonpeptidic dendrimers show promise as efficient molecular translocators.
- The developed dendritic structures hold significant potential for intracellular delivery of drugs, peptides, and proteins.